Literature DB >> 11059948

Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study Group.

B M Farr1, C L Bartlett, J Wadsworth, D L Miller.   

Abstract

A case-control study of risk factors for community-acquired pneumonia in adults admitted to hospital is reported. Cases were surviving patients (n = 178) admitted to 14 hospitals in England. Controls were individuals (n = 385) randomly selected from the electoral registers of the areas served by the hospitals. The two groups were compared with regard to risk factors for pneumonia using a standardized postal questionnaire. Independent risk factors associated with cases in log-linear regression analysis were age, heart disease (as indicated by congestive heart failure and/or digitalis treatment), lifetime smoking history, chronic airway disease (chronic bronchitis and/or asthma), occupational dust exposure, pneumonia as a child, single marital status and unemployment. Corticosteroid and bronchodilator therapy were also independent risk factors in the log-linear regression analysis, but may reflect the severity of underlying lung disease for which these drugs were prescribed. These data suggest that cigarette smoking is the major avoidable risk factor for acute pneumonia in adults.

Entities:  

Mesh:

Year:  2000        PMID: 11059948     DOI: 10.1053/rmed.2000.0865

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  42 in total

1.  Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.

Authors:  Dennis Chen; Marcos I Restrepo; Michael J Fine; Mary Jo V Pugh; Antonio Anzueto; Mark L Metersky; Brandy Nakashima; Chester Good; Eric M Mortensen
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

2.  An exploratory spatial analysis of pneumonia and influenza hospitalizations in Ontario by age and gender.

Authors:  E J Crighton; S J Elliott; R Moineddin; P Kanaroglou; R E G Upshur
Journal:  Epidemiol Infect       Date:  2006-07-07       Impact factor: 2.451

Review 3.  The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics.

Authors:  Richard N van Zyl-Smit; Laurence Brunet; Madhukar Pai; Wing-Wai Yew
Journal:  Infect Dis Clin North Am       Date:  2010-09       Impact factor: 5.982

Review 4.  Management of community-acquired pneumonia in older adults.

Authors:  Antonella F Simonetti; Diego Viasus; Carolina Garcia-Vidal; Jordi Carratalà
Journal:  Ther Adv Infect Dis       Date:  2014-02

Review 5.  Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature.

Authors:  Ella M Meumann; Allen C Cheng; Linda Ward; Bart J Currie
Journal:  Clin Infect Dis       Date:  2011-11-04       Impact factor: 9.079

Review 6.  Inhaled corticosteroids and the increased risk of pneumonia: what's new? A 2015 updated review.

Authors:  Hernan Iannella; Carlos Luna; Grant Waterer
Journal:  Ther Adv Respir Dis       Date:  2016-02-18       Impact factor: 4.031

Review 7.  Particle exposures and infections.

Authors:  A J Ghio
Journal:  Infection       Date:  2014-02-02       Impact factor: 3.553

Review 8.  Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients.

Authors:  T T Dang; S R Majumdar; T J Marrie; D T Eurich
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 3.923

9.  Pharmacotherapy and the risk for community-acquired pneumonia.

Authors:  Jen-Tzer Gau; Utkarsh Acharya; Salman Khan; Victor Heh; Lona Mody; Tzu-Cheg Kao
Journal:  BMC Geriatr       Date:  2010-07-06       Impact factor: 3.921

Review 10.  An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease.

Authors:  Sonal Singh; Yoon K Loke
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.